Envestnet Asset Management Inc. Sells 6,092 Shares of Masimo Corporation $MASI

Envestnet Asset Management Inc. lessened its position in shares of Masimo Corporation (NASDAQ:MASI) by 22.4% in the third quarter, according to its most recent filing with the SEC. The firm owned 21,142 shares of the medical equipment provider’s stock after selling 6,092 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Masimo were worth $3,120,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MASI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Masimo by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock worth $1,894,000 after buying an additional 66 shares during the period. Assetmark Inc. boosted its position in Masimo by 5.0% during the second quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider’s stock valued at $259,000 after acquiring an additional 73 shares during the last quarter. ProShare Advisors LLC grew its holdings in Masimo by 5.3% during the 2nd quarter. ProShare Advisors LLC now owns 1,995 shares of the medical equipment provider’s stock worth $336,000 after acquiring an additional 101 shares during the period. Orion Porfolio Solutions LLC raised its position in shares of Masimo by 2.2% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 4,871 shares of the medical equipment provider’s stock worth $819,000 after acquiring an additional 104 shares in the last quarter. Finally, MAI Capital Management lifted its stake in shares of Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 129 shares during the period. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Performance

Shares of MASI stock opened at $175.10 on Thursday. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69. The firm has a fifty day simple moving average of $141.50 and a two-hundred day simple moving average of $143.65. Masimo Corporation has a 12 month low of $125.94 and a 12 month high of $194.88. The firm has a market capitalization of $9.40 billion, a PE ratio of -16.61, a price-to-earnings-growth ratio of 1.78 and a beta of 1.26.

Analysts Set New Price Targets

Several equities research analysts recently commented on MASI shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. Bank of America began coverage on shares of Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 price objective for the company. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research report on Tuesday, February 17th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Monday, December 1st. Finally, BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. One analyst has rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $181.17.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.